EAE: pitfalls outweigh virtues of screening potential treatments for multiple sclerosis
- 30 April 2006
- journal article
- other
- Published by Elsevier in Trends in Immunology
- Vol. 27 (4) , 167-168
- https://doi.org/10.1016/j.it.2006.02.007
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Virtues and pitfalls of EAE for the development of therapies for multiple sclerosisPublished by Elsevier ,2005
- Disease models of autoimmunityTrends in Immunology, 2005
- New directions in MS therapeutics: vehicles of hopeTrends in Immunology, 2004
- Considerations with the use of biological therapy in the treatment of rheumatoid arthritisExpert Opinion on Drug Safety, 2004
- An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptideNature Immunology, 2001
- Serial contrast-enhanced magnetic resonance imaging in patients with early relapsing-remitting multiple sclerosis: Implications for treatment trialsAnnals of Neurology, 1994